Shenzhen Glory Medical Co Ltd Tangible Net Worth Ratio
Shenzhen Glory Medical Co Ltd tangible net worth ratio. Shenzhen Glory Medical Co Ltd (002551) has a Tangible Net Worth Ratio of 90.7% as of June 2026. This metric is calculated by deducting intangible assets (CN¥241.13 Million) from net assets (CN¥2.59 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check strategic asset allocation of Shenzhen Glory Medical Co Ltd to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Shenzhen Glory Medical Co Ltd (2007–2025)
Tangible net worth ratio of Shenzhen Glory Medical Co Ltd from 2007 to 2025. This chart shows how Shenzhen Glory Medical Co Ltd's Tangible Net Worth Ratio has changed across 19 annual periods from 2007 to 2025. As of June 2026, the ratio stands at 90.7%, reflecting net assets of CN¥2.59 Billion with intangible assets of CN¥241.13 Million CNY. See 002551 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Shenzhen Glory Medical Co Ltd Tangible Net Worth Ratio by Year (2007–2025)
Shenzhen Glory Medical Co Ltd tangible net worth ratio by year from 2007 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Shenzhen Glory Medical Co Ltd from 2007 to 2025, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 002551 stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 90.5% | CN¥2.62 Billion | CN¥248.29 Million | CN¥3.33 Billion | ▲ +0.6 pp |
| 2024 | 89.9% | CN¥2.78 Billion | CN¥280.36 Million | CN¥3.88 Billion | ▲ +0.1 pp |
| 2023 | 89.8% | CN¥2.75 Billion | CN¥280.36 Million | CN¥3.93 Billion | ▲ +6.8 pp |
| 2022 | 83.0% | CN¥3.00 Billion | CN¥510.02 Million | CN¥4.26 Billion | ▼ -9.0 pp |
| 2021 | 92.0% | CN¥3.45 Billion | CN¥275.61 Million | CN¥4.97 Billion | ▼ -2.0 pp |
| 2020 | 94.0% | CN¥3.65 Billion | CN¥217.22 Million | CN¥5.06 Billion | ▲ +2.3 pp |
| 2019 | 91.7% | CN¥2.82 Billion | CN¥233.61 Million | CN¥4.72 Billion | ▲ +0.2 pp |
| 2018 | 91.5% | CN¥2.78 Billion | CN¥235.15 Million | CN¥4.10 Billion | ▲ +0.4 pp |
| 2017 | 91.2% | CN¥2.67 Billion | CN¥236.47 Million | CN¥4.31 Billion | ▲ +2.3 pp |
| 2016 | 88.9% | CN¥2.17 Billion | CN¥241.71 Million | CN¥4.06 Billion | ▼ -0.8 pp |
| 2015 | 89.7% | CN¥1.58 Billion | CN¥163.02 Million | CN¥2.96 Billion | ▲ +0.1 pp |
| 2014 | 89.6% | CN¥1.46 Billion | CN¥151.36 Million | CN¥2.36 Billion | ▼ -5.8 pp |
| 2013 | 95.4% | CN¥1.33 Billion | CN¥61.08 Million | CN¥2.02 Billion | ▼ -3.6 pp |
| 2012 | 99.0% | CN¥1.22 Billion | CN¥11.86 Million | CN¥1.52 Billion | ▲ +0.1 pp |
| 2011 | 99.0% | CN¥1.18 Billion | CN¥12.14 Million | CN¥1.33 Billion | ▲ +3.5 pp |
| 2010 | 95.5% | CN¥276.00 Million | CN¥12.43 Million | CN¥488.62 Million | ▲ +1.0 pp |
| 2009 | 94.5% | CN¥229.22 Million | CN¥12.71 Million | CN¥403.05 Million | ▲ +2.0 pp |
| 2008 | 92.5% | CN¥172.19 Million | CN¥13.00 Million | CN¥318.10 Million | ▲ +8.4 pp |
| 2007 | 84.1% | CN¥83.05 Million | CN¥13.23 Million | CN¥210.70 Million | — |